According to FutureWise analysis the market for Non Invasive Prenatal Testing is expected to reach US$ 17.95 billion by 2031 at a CAGR of 13.70%.
In non-invasive prenatal testing (NIPT), blood samples from a pregnant woman are tested for abnormalities within the fetus. Test results are analyzed using DNA fragments from the mother's blood in order to diagnose genetic disorders such as Down syndrome , Edwards syndrome , Patau syndrome, and Turner syndrome. This procedure eliminates the need for chorionic villus sampling (CVS), an invasive and precarious procedure, and can be performed at any time after nine weeks of pregnancy. There are growing numbers of genetic disorders of the fetus, which is one of the key factors driving the market's growth. Furthermore, technological advancements in the life sciences and healthcare industries are also driving the market. As an example, the development of DNA sequencing technologies, regenerative medicines and breakthroughs in molecular research have opened up immense possibilities to combat any serious disease at its earliest stages. Also driving the growth of the market are rising health consciousness and awareness about the importance and benefits of prenatal testing, as well as increasing acceptance and acceptance rates of such tests. It is becoming more common for healthcare providers, as well as expecting parents, to use alternative diagnostic methods to diagnose and treat other genetic disorders, such as spina bifida, cleft palate, and sickle cell anemia. Additionally, the shifting trend toward childbearing at a high maternal age is positively impacting the market growth. There are a number of health complications that can occur as a mother's age advances. These complications can include high blood pressure, reduced fertility, miscarriage risk, and chromosomal abnormalities in the fetus.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Non Invasive Prenatal Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Non Invasive Prenatal Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.